UK Scientists Developing Ebola Vaccine Ready for Trials in Months

UK scientists are developing a vaccine for the current Ebola outbreak in the Democratic Republic of Congo, with clinical trials expected to begin within months.

The outbreak involves the rare Bundibugyo species of Ebola, which kills approximately one-third of those infected and has no approved vaccine. The WHO has upgraded its risk assessment, saying the outbreak is “spreading rapidly.”

In eastern DR Congo, angry crowds burned medical tents after being prevented from burying the body of a suspected Ebola victim, highlighting community resistance to containment measures.

If successful, the UK-developed vaccine would become a critical tool against the Bundibugyo strain. Vaccines for the more common Zaire strain have proven effective in past outbreaks, but Bundibugyo vaccine development remains in early stages.